COVID-19 疫苗接种意向和炎症性肠病患者的认知。
COVID-19 Vaccination Intent and Perceptions Among Patients With Inflammatory Bowel Diseases.
机构信息
Division of Gastroenterology, Hepatology and Endoscopy, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Division of Gastroenterology, Hepatology and Endoscopy, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
出版信息
Clin Gastroenterol Hepatol. 2021 Aug;19(8):1730-1732.e2. doi: 10.1016/j.cgh.2021.02.004. Epub 2021 Feb 4.
Abstract
Patients with inflammatory bowel disease (IBD) develop coronavirus disease 2019 (COVID-19) at similar rates as the general population, and there was initial concern regarding potential for severe illness. Vaccinations were authorized for emergency use in the United States in December 2020 and aim to halt the spread of COVID-19. However, there are concerns that people will be hesitant to receive the vaccine for a variety of reasons including insufficient data in certain populations including those with IBD. We surveyed patients with IBD to identify potential concerns regarding COVID-19 vaccination.
摘要
患有炎症性肠病 (IBD) 的患者感染 2019 年冠状病毒病 (COVID-19) 的比率与一般人群相似，最初人们担心可能会出现重症。疫苗于 2020 年 12 月在美国获准紧急使用，旨在阻止 COVID-19 的传播。然而，人们担心出于各种原因，包括某些人群（包括 IBD 患者）的数据不足，人们会不愿意接种疫苗。我们调查了 IBD 患者，以确定他们对 COVID-19 疫苗接种的潜在担忧。
相似文献
1
COVID-19 Vaccination Intent and Perceptions Among Patients With Inflammatory Bowel Diseases.COVID-19 疫苗接种意向和炎症性肠病患者的认知。
Clin Gastroenterol Hepatol. 2021 Aug;19(8):1730-1732.e2. doi: 10.1016/j.cgh.2021.02.004. Epub 2021 Feb 4.
2
[SARS-CoV-2 Vaccination for Adult Patients with Inflammatory Bowel Disease: Expert Consensus Statements by KASID].[成人炎症性肠病患者的新型冠状病毒2型疫苗接种：韩国炎症性肠病学会专家共识声明]
Korean J Gastroenterol. 2021 Aug 25;78(2):117-128. doi: 10.4166/kjg.2021.110.
3
BRAZILIAN IBD STUDY GROUP POSITION STATEMENT ON SARS-COV2 VACCINATION.巴西炎症性肠病研究小组关于新冠病毒疫苗接种的立场声明。
Arq Gastroenterol. 2021 Jan-Mar;58(1):1-4. doi: 10.1590/S0004-2803.202100000-02.
4
COVID-19 Vaccination Coverage, Intent, Knowledge, Attitudes, and Beliefs among Essential Workers, United States.美国基本劳动者的 COVID-19 疫苗接种率、意向、知识、态度和信念。
Emerg Infect Dis. 2021 Nov;27(11):2908-2913. doi: 10.3201/eid2711.211557. Epub 2021 Sep 29.
5
SARS-CoV-2 vaccination does not induce relapses of patients with inflammatory bowel disease.接种 SARS-CoV-2 疫苗不会导致炎症性肠病患者复发。
Z Gastroenterol. 2022 Jan;60(1):77-80. doi: 10.1055/a-1710-3861. Epub 2022 Jan 18.
6
SARS-CoV-2-inactivated vaccine hesitancy and the safety in inflammatory bowel disease patients: a single-center study.严重急性呼吸综合征冠状病毒2型灭活疫苗在炎症性肠病患者中的犹豫态度及安全性：一项单中心研究
Therap Adv Gastroenterol. 2022 Jun 11;15:17562848221101722. doi: 10.1177/17562848221101722. eCollection 2022.
7
The COVID-19 Vaccination Hesitancy Among the People With Inflammatory Bowel Disease in China: A Questionnaire Study.中国炎症性肠病患者对 COVID-19 疫苗接种的犹豫：一项问卷调查研究。
Front Public Health. 2021 Oct 11;9:731578. doi: 10.3389/fpubh.2021.731578. eCollection 2021.
8
Inflammatory Bowel Disease and COVID-19 Vaccination: A Patients' Survey.炎症性肠病与 COVID-19 疫苗接种：患者调查。
Dig Dis Sci. 2022 Jun;67(6):2067-2073. doi: 10.1007/s10620-021-07040-z. Epub 2021 May 12.
9
COVID-19 Vaccination Intent, Perceptions, and Reasons for Not Vaccinating Among Groups Prioritized for Early Vaccination - United States, September and December 2020.2020 年 9 月和 12 月美国优先接种人群的 COVID-19 疫苗接种意愿、认知和不接种原因。
MMWR Morb Mortal Wkly Rep. 2021 Feb 12;70(6):217-222. doi: 10.15585/mmwr.mm7006e3.
10
Low Rates of Breakthrough COVID-19 Infection After SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease.炎症性肠病患者接种新型冠状病毒疫苗后新冠病毒突破性感染率较低
Inflamm Bowel Dis. 2023 Mar 1;29(3):483-486. doi: 10.1093/ibd/izac138.
引用本文的文献
1
Unreliable information and fear: Barriers to vaccination among IBD patients in China.不可靠信息与恐惧：中国炎症性肠病患者的疫苗接种障碍
Hum Vaccin Immunother. 2025 Dec;21(1):2446071. doi: 10.1080/21645515.2024.2446071. Epub 2025 Jan 24.
2
Vaccine Acceptance in Patients with Inflammatory Bowel Disease: Lessons Learned from the COVID-19 Pandemic.炎症性肠病患者对疫苗的接受度：从新冠疫情中吸取的教训
Vaccines (Basel). 2024 May 18;12(5):551. doi: 10.3390/vaccines12050551.
3
Role of gastroenterologists and healthcare providers in promoting COVID-19 immunization among individuals with inflammatory bowel disease: A systematic review and meta-analysis on a global scale.全球范围内胃肠病学家和医疗保健提供者在促进炎症性肠病患者 COVID-19 免疫接种中的作用：系统评价和荟萃分析。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2349319. doi: 10.1080/21645515.2024.2349319. Epub 2024 May 16.
4
Effects of COVID-19 vaccines on patient-reported outcomes in patients with inflammatory bowel disease: a multicenter survey study in Korea.新型冠状病毒肺炎疫苗对炎症性肠病患者自我报告结局的影响：韩国一项多中心调查研究
Intest Res. 2024 Jul;22(3):336-350. doi: 10.5217/ir.2023.00077. Epub 2024 Mar 26.
5
A Practical Update on COVID-19 and Inflammatory Bowel Disease: COVID-19 Disease Risk and Vaccine Safety and Efficacy.新型冠状病毒肺炎与炎症性肠病实用最新进展：新型冠状病毒肺炎疾病风险及疫苗安全性与有效性
Gastroenterol Hepatol (N Y). 2024 Feb;20(2):88-97.
6
SARS-CoV-2 vaccination in inflammatory bowel disease patients is not associated with flares: a retrospective single-centre Swiss study.炎症性肠病患者接种 SARS-CoV-2 疫苗与疾病活动无关：一项瑞士单中心回顾性研究。
Ann Med. 2024 Dec;56(1):2295979. doi: 10.1080/07853890.2023.2295979. Epub 2024 Jan 30.
7
Postvaccination Symptoms After SARS-CoV-2 mRNA Vaccination Among Patients With Inflammatory Bowel Disease: A Prospective, Comparative Study.接种 SARS-CoV-2 mRNA 疫苗后炎症性肠病患者的疫苗接种后症状：一项前瞻性、对照研究。
Inflamm Bowel Dis. 2024 Apr 3;30(4):602-616. doi: 10.1093/ibd/izad114.
8
Decrease in Overall Vaccine Hesitancy in College Students during the COVID-19 Pandemic.新冠疫情期间大学生总体疫苗犹豫情况的下降
Vaccines (Basel). 2023 Jun 21;11(7):1132. doi: 10.3390/vaccines11071132.
9
Low vaccination and infection rate of Omicron in patients with inflammatory bowel disease: a comparative study of three unique cohorts.炎症性肠病患者中奥密克戎的低疫苗接种率和感染率：三个独特队列的对比研究。
Front Public Health. 2023 Jun 15;11:1115127. doi: 10.3389/fpubh.2023.1115127. eCollection 2023.
10
Vaccines - beliefs and concerns: the voice of patients with inflammatory immunomediated diseases.疫苗——信念与担忧：炎症性免疫介导性疾病患者的心声。
Eur J Gastroenterol Hepatol. 2023 Aug 1;35(8):848-853. doi: 10.1097/MEG.0000000000002589. Epub 2023 Jun 6.
本文引用的文献
1
Are Patients With Inflammatory Bowel Disease at an Increased Risk of Developing SARS-CoV-2 than Patients Without Inflammatory Bowel Disease? Results From a Nationwide Veterans' Affairs Cohort Study.炎症性肠病患者感染 SARS-CoV-2 的风险是否高于非炎症性肠病患者？一项全国退伍军人事务队列研究的结果。
Am J Gastroenterol. 2021 Apr;116(4):808-810. doi: 10.14309/ajg.0000000000001012.
2
Effect of IBD medications on COVID-19 outcomes: results from an international registry.IBD 药物对 COVID-19 结局的影响：来自国际注册研究的结果。
Gut. 2021 Apr;70(4):725-732. doi: 10.1136/gutjnl-2020-322539. Epub 2020 Oct 20.
3
Clinical Outcomes of Covid-19 in Patients With Inflammatory Bowel Disease: A Nationwide Cohort Study.炎症性肠病患者 COVID-19 的临床结局：一项全国性队列研究。
J Crohns Colitis. 2021 Apr 6;15(4):529-539. doi: 10.1093/ecco-jcc/jjaa215.
4
Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry.皮质类固醇，而不是 TNF 拮抗剂，与炎症性肠病患者 COVID-19 不良结局相关：来自国际登记处的结果。
Gastroenterology. 2020 Aug;159(2):481-491.e3. doi: 10.1053/j.gastro.2020.05.032. Epub 2020 May 18.
5
The REDCap consortium: Building an international community of software platform partners.REDCap 联盟：构建软件平台合作伙伴的国际社区。
J Biomed Inform. 2019 Jul;95:103208. doi: 10.1016/j.jbi.2019.103208. Epub 2019 May 9.
6
Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.研究电子数据采集（REDCap）——一种用于提供转化研究信息学支持的元数据驱动方法和工作流程。
J Biomed Inform. 2009 Apr;42(2):377-81. doi: 10.1016/j.jbi.2008.08.010. Epub 2008 Sep 30.
Zotero 插件